Cargando…
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab
Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biologic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688342/ https://www.ncbi.nlm.nih.gov/pubmed/29230331 http://dx.doi.org/10.1155/2017/3280215 |
_version_ | 1783279141231001600 |
---|---|
author | Ghoneim, Sara Ramos-Rodriguez, Alvaro J. Vazquez de Lara, Fernando Bonomo, Lauren |
author_facet | Ghoneim, Sara Ramos-Rodriguez, Alvaro J. Vazquez de Lara, Fernando Bonomo, Lauren |
author_sort | Ghoneim, Sara |
collection | PubMed |
description | Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biological agents reported in the literature. We report a case of a 25-year-old African-American female who presented with asymptomatic hyperkeratotic papules along the lines of Blaschko and was subsequently diagnosed with linear psoriasis. After failing conventional treatment regimens, the patient received a trial of ixekizumab with complete resolution of cutaneous lesions reported after 4 months and only 8 doses of the anti-IL-17 biologic agent. |
format | Online Article Text |
id | pubmed-5688342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-56883422017-12-11 The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab Ghoneim, Sara Ramos-Rodriguez, Alvaro J. Vazquez de Lara, Fernando Bonomo, Lauren Case Rep Dermatol Med Case Report Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biological agents reported in the literature. We report a case of a 25-year-old African-American female who presented with asymptomatic hyperkeratotic papules along the lines of Blaschko and was subsequently diagnosed with linear psoriasis. After failing conventional treatment regimens, the patient received a trial of ixekizumab with complete resolution of cutaneous lesions reported after 4 months and only 8 doses of the anti-IL-17 biologic agent. Hindawi 2017 2017-11-02 /pmc/articles/PMC5688342/ /pubmed/29230331 http://dx.doi.org/10.1155/2017/3280215 Text en Copyright © 2017 Sara Ghoneim et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ghoneim, Sara Ramos-Rodriguez, Alvaro J. Vazquez de Lara, Fernando Bonomo, Lauren The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title | The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_full | The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_fullStr | The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_full_unstemmed | The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_short | The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_sort | successful treatment of a case of linear psoriasis with ixekizumab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688342/ https://www.ncbi.nlm.nih.gov/pubmed/29230331 http://dx.doi.org/10.1155/2017/3280215 |
work_keys_str_mv | AT ghoneimsara thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT ramosrodriguezalvaroj thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT vazquezdelarafernando thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT bonomolauren thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT ghoneimsara successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT ramosrodriguezalvaroj successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT vazquezdelarafernando successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT bonomolauren successfultreatmentofacaseoflinearpsoriasiswithixekizumab |